Role of circulating tumor cell detection in differentiating tumor recurrence from treatment necrosis of brain gliomas-Reference-Cited by-同舟云学术

Role of circulating tumor cell detection in differentiating tumor recurrence from treatment necrosis of brain gliomas

Published:2021-04-30 Issue:2 Volume:15 Page:107-117
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Gao Faliang¹²³,Zhao Wenyan⁴,Li Mingxiao²³,Ren Xiaohui²³,Jiang Haihui²³,Cui Yong²³,Lin Song²³

Affiliation:

1. Department of Neurosurgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China; Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, China.

2. Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

3. China National Clinical Research Center for Neurological Diseases, Beijing, China.

4. General Practice Department, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health (social science)

Link

https://www.jstage.jst.go.jp/article/bst/15/2/15_2021.01017/_pdf

Reference37 articles.

1. 1. Stupp R, Mason WP, Van Den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352:987-996.

2. 2. Peca C, Pacelli R, Elefante A, De Caro MDB, Vergara P, Mariniello G, Giamundo A, Maiuri F. Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: tumour progression or radionecrosis? Clin Neurol Neurosurg. 2009; 111:331-334.

3. 3. Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010; 28:1963-1972.

4. 4. Melguizo-Gavilanes I, Bruner JM, Guha-Thakurta N, Hess KR, Puduvalli VK. Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard? J Neurooncol. 2015; 123:141-150.

5. 5. Strauss SB, Meng A, Ebani EJ, Chiang GC. Imaging glioblastoma posttreatment: progression, pseudoprogression, pseudoresponse, radiation necrosis. Neuroimaging Clin N Am. 2021; 31:103-120.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted co-delivery of PD-L1 monoclonal antibody and sorafenib to circulating tumor cells via platelet-functionalized nanocarriers;Biochemical and Biophysical Research Communications;2023-09

2. Latest updates on cellular and molecular biomarkers of gliomas;Frontiers in Oncology;2022-11-08

3. Circulating Tumor Cells and Cell-free Tumor DNA in Evaluation and Management of Gliomas;Advances in Oncology;2022-05